Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
03/05/2014 | CN102895386B Method for performing extraction on angelica dahurica, common cnidium fruit, Chinese red pepper and elecampane inula root and pharmaceutical application |
03/05/2014 | CN102895213B Stable cefotiam hexetil hydrochloride composition |
03/05/2014 | CN102864157B Immune protective antigen of haemophilus parasuis |
03/05/2014 | CN102838623B Cefminox sodium compound crystal, preparation method of cefminox sodium compound crystal and sterile powder injection containing cefminox sodium compound crystal |
03/05/2014 | CN102836318B Washing liquid for gardnerella vaginitis |
03/05/2014 | CN102836247B Tangerine extract composition for feminite care |
03/05/2014 | CN102813626B Amorphous form cefmenoxime hydrochloride compound combination for injection |
03/05/2014 | CN102772764B Nursing traditional Chinese medicine disinfectant and preparation method |
03/05/2014 | CN102772747B Traditional Chinese medicine preparation for treating heat-toxicity heart-disoperation type viral myocarditis |
03/05/2014 | CN102772420B Swine bile phthalate eye drops and preparation method thereof |
03/05/2014 | CN102731344B Hydrazine nitrile cathepsin inhibitors with different P<3> structures, and application thereof |
03/05/2014 | CN102727605B Oral liquid for treating vital myocarditis |
03/05/2014 | CN102702351B Humanized EV71 antivirus neutralizing antibody EV71FabL6 and preparation method and application thereof |
03/05/2014 | CN102697895B Method for continuously extracting total polyphenol, chlorogenic acid and phlorizin from green apples |
03/05/2014 | CN102671102B Traditional Chinese medicine composition for treating chronic hepatitis B |
03/05/2014 | CN102617712B Polypeptide for effectively restraining activity of influenza virus polymerase |
03/05/2014 | CN102603964B Water-soluble polymer iron chelator as well as preparation method and application thereof |
03/05/2014 | CN102585034B Method for sulfonating pectin |
03/05/2014 | CN102580115B Tuberculosis mucosa gene vaccine assembled by using chitosan oligosaccharide delivery system and preparation and application of tuberculosis mucosa gene vaccine |
03/05/2014 | CN102558126B 2-substituted chromone compound, as well as preparation method and application thereof |
03/05/2014 | CN102414199B Diaryl ethers |
03/05/2014 | CN102380101B Pholcodine-containing compound pharmaceutical preparation for treating cold |
03/05/2014 | CN102307890B Hepatitis c virus inhibitors |
03/05/2014 | CN102178604B Device and method for preparing gel microsphere and gel microsphere in which antitubercular agents can be injected |
03/05/2014 | CN102172262B Enzyme treatment for infection |
03/05/2014 | CN102106842B Levofloxacin hydrochloride micropill capsule and preparation method thereof |
03/05/2014 | CN102048677B Valganciclovir Hydrochloride solid preparation and preparation method thereof |
03/05/2014 | CN101951762B Foam stabilizer composition |
03/05/2014 | CN101795713B Conjugate purification |
03/05/2014 | CN101785779B Separation and preparation of isovaleryl-spiramycin II |
03/05/2014 | CN101248038B Crystalline solid forms of tigecycline and methods of preparing same |
03/05/2014 | CN101166828B Enzymatic production of peracids using perhydrolytic enzymes |
03/04/2014 | US8666680 Recombinant soluble FC receptors |
03/04/2014 | US8664382 Antibacterial compositions comprising metal phthalocyanine analogues |
03/04/2014 | US8664360 BSL3 polypeptides |
03/04/2014 | US8664224 External preparation for athlete's foot treatment |
03/04/2014 | US8663916 Methods for producing antifungal bifunctional molecules for treating fungal infection |
03/04/2014 | US8663656 Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages |
03/04/2014 | US8663629 Kallikrein-binding “kunitz domain” proteins and analogues thereof |
03/04/2014 | CA2551644C Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of usethereof |
03/04/2014 | CA2533918C Use of adcc-optimized antibodies for treating weak patients |
03/04/2014 | CA2444164C Pufa polyketide synthase systems and uses thereof |
02/27/2014 | WO2014030801A1 Novel anti-fungal peptide pg-2 derived from gogu valley potato, and use thereof |
02/27/2014 | WO2014030020A1 Therapeutic bacteriophages |
02/27/2014 | WO2014029498A1 Bixiamycins and sulfonylbixiamycins |
02/27/2014 | WO2014029193A1 Dihydropyrimidine compounds and their application in pharmaceuticals |
02/27/2014 | WO2014002035A3 A human monoclonal antibody against the vp1 protein of jc virus |
02/27/2014 | WO2013188870A3 IgA CD4i ANTIBODIES AND METHODS OF TREATMENT USING SAME |
02/27/2014 | US20140057869 Novel Pharmaceutical Agents Containing Carbohydrate Moieties And Methods Of Their Preparation And Use |
02/27/2014 | US20140057863 Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation |
02/27/2014 | US20140056974 Spontaneously Dispersible N-Benzoyl Staurosporine Compositions |
02/27/2014 | US20140056947 Virus traps |
02/27/2014 | US20140056927 Lipotheichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
02/27/2014 | US20140056923 Method of treating hypertension disorder and a pharmaceutical agent |
02/27/2014 | US20140056922 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation |
02/27/2014 | US20140056809 Treatment and diagnosis of macrophage mediated disease |
02/27/2014 | CA2876690A1 Dihydropyrimidine compounds and their application in pharmaceuticals |
02/26/2014 | EP2700638A1 Purine analogs |
02/26/2014 | EP2700412A1 PROBIOTICS, SECRETORY IgA AND INFLAMMATION |
02/26/2014 | EP2700411A1 Probiotics, secretory IgA and infection |
02/26/2014 | EP2700409A1 IL-27 for modulation of immune response in acute lung disease |
02/26/2014 | EP2700407A1 Granules in liquid dosage form |
02/26/2014 | EP2700406A1 METHOD FOR PRODUCING POLYGONUM TINCTORIUM EXTRACT& xA; |
02/26/2014 | EP2699595A1 Fusion peptide designed to reduce plaque bacteria and yeast in the oral cavity |
02/26/2014 | EP2699573A2 7-(3,5-dimethyl-4-isoxazolyl)-8-(methyloxy)-1h-imidazo[4,5-c]quinoline derivatives |
02/26/2014 | EP2699566A1 Phenyl-isoxazol derivatives and preparation process thereof |
02/26/2014 | EP2699558A1 Benzothiazole compounds and their pharmaceutical use |
02/26/2014 | EP2699557A1 Aromatic amides and uses thereof |
02/26/2014 | EP2699257A1 Peptide and conjugate vaccines for fungal infections |
02/26/2014 | EP2699246A1 Method of inhibiting harmful microorganisms and barrier-forming composition therefor |
02/26/2014 | EP2699241A1 Antiviral compounds |
02/26/2014 | EP2699239A2 Medical products for use in conditions related to microbial infections in the upper aerodigestive tract |
02/26/2014 | EP2699238A2 Antiviral compositions directed against the influenza virus nucleoprotein |
02/26/2014 | CN103608020A Method of treating dengue fever |
02/26/2014 | CN103608014A Use of kinase inhibitors in preventing and treating inflammatory disorder |
02/26/2014 | CN103608008A Non-leaching antimicrobial wound dressing |
02/26/2014 | CN103608006A New combination comprising N-acetyl-L-cysteine and its use |
02/26/2014 | CN103602689A Development of dengue virus vaccine components |
02/26/2014 | CN103602639A Method of harvesting viruses by low-osmotic-pressure harvest liquid |
02/26/2014 | CN103602638A Recombinant equine influenza virus strain, preparation method thereof and vaccine prepared from recombinant equine influenza virus strain |
02/26/2014 | CN103602629A Methods for culturing swine testis cell in serum-free manner and producing classical swine fever cell vaccine by using swine testis cell |
02/26/2014 | CN103602614A Preparation and application of composite microecological feed additive |
02/26/2014 | CN103601828A Complex polymer and applications thereof |
02/26/2014 | CN103601809A HCV multi-epitope peptide, truncated NS3, and DC activating molecule EDA recombinant protein vaccine and applications thereof |
02/26/2014 | CN103601800A Mono- and di-PEG IL-10 production, and uses |
02/26/2014 | CN103601795A Scylla paramamosain anti-fungal anti-lipopolysaccharide factor, as well as preparation method and application thereof |
02/26/2014 | CN103601787A Glycyrrhizic acid derivative and synthesis method thereof |
02/26/2014 | CN103601727A Use of novel amine compound modified protoporphyrin |
02/26/2014 | CN103601724A Novel oxazolidinone compound, as well as preparation method and application thereof |
02/26/2014 | CN103601721A 3-furylbis(benzodiazepine)-1-one series derivatives, and preparation method and application thereof |
02/26/2014 | CN103601690A 3-phenylbis(benzodiazepine)-1-one series derivatives, and preparation method and application thereof |
02/26/2014 | CN103601683A Benzohetercyclic compounds, preparation method thereof and applications thereof |
02/26/2014 | CN103601676A Synthetic method for high-enantioselectivity N-acetyl-2-substitued-2, 3-dihydro-4-quinolinone compounds |
02/26/2014 | CN103601670A Piplartine analogue, and preparation method and application thereof |
02/26/2014 | CN103601663A Tryptamine derivative compound and preparation method and purpose thereof |
02/26/2014 | CN103601621A Schisandrin and pharmaceutical application thereof |
02/26/2014 | CN103599594A Device for treating nodule in breast |
02/26/2014 | CN103599538A Preparation method of polymer nanoparticles containing antiretroviral drugs |
02/26/2014 | CN103599535A External ointment prepared from i26 immune egg powder and traditional Chinese medicine decoction |
02/26/2014 | CN103599534A Preparation method and use of poultry vaccine-specific pig spleen transfer factor |